Papers

1

Total Citations

5

H-Index

1

About

Dr. Xuping Xie is a leading virologist whose research focuses on emerging viral pathogens, particularly SARS-CoV-2 and other high-consequence RNA viruses. Her major contributions center on developing innovative, safe, and scalable tools for studying viral neutralization and pathogenesis. Notably, she pioneered an integrated research-clinical BSL-2 platform for a live SARS-CoV-2 neutralization assay, utilizing a highly attenuated virus (Δ3678_WA1-s) to enable reliable serological monitoring of neutralizing antibodies against SARS-CoV-2 and its variants of concern. This work, published in 2023, has already garnered significant attention with 5 citations, underscoring its practical impact in both clinical and research settings. Dr. Xie’s achievements are particularly remarkable for bridging the gap between high-containment laboratory research and real-world clinical application, making critical assays more accessible and safer. Her innovative approach has been instrumental in tracking immune responses and guiding vaccine and therapeutic development during the COVID-19 pandemic. Through her dedication to virology and public health, Dr. Xie continues to shape our understanding of viral immunity and contribute essential tools for pandemic preparedness.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
An Integrated Research–Clinical BSL-2 Platform for a Live SARS-CoV-2 Neutralization Assay
5 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: The University of Texas Medical Branch at Galveston

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago